I will always support treating drug use as a health issue above anything else, so obviously I would support giving help to people struggling with it.
The Bill addresses the difficulties that have arisen in controlling the use of these substances under the Misuse of Drugs Act 1971. The SNP supports the aims of the Bill, and the Scottish Government have been working with the Home Office and other partners in combating the use of harmful NPSs. Let us not pretend that they are not harmful. A Scottish Drugs Forum survey of drug services in 2013 provided a summary of some of the key harms associated with NPS use—overdose and temporary psychotic states, attendance at A and E, hospital admissions, sudden increase in body temperature and heart rate, coma, risk to internal organs, hallucination and vomiting. The list goes on. Some would argue that many of these effects can occur as a result of alcohol abuse, but with these substances no abuse is necessary; simply their use can have catastrophic effects. There were also some associated long-term health issues such as an increase in mental health issues, including psychosis, paranoia, anxiety, psychiatric complications and depression —and dependency, which can happen over a very short period of time, sometimes just a matter of weeks.
Many hon. Members will have received correspondence from their constituents, and today we have heard some horrifying examples of the impact of these substances. Faced with a personal testimony and a growing body of research from health practitioners and academic researchers, we have a duty as legislators to get this legislation right. We are not yet there. The Committee must explore in detail some of the concerns raised today, including the issue of driving sales underground, internet sales and how to ban them, either on the clearnet or the darknet, and the issue of proportionality in sentencing, which the hon. Member for West Ham (Lyn Brown) mentioned. There are many other issues, too.
The Scottish Government have commissioned research to look at trends and, more importantly, at the motivations of those consuming these substances. In February this year, the expert review group commissioned by the Scottish Government put forward a number of recommendations, which should be of interest to Members in debating the Bill. One of these was the development of a definition of “new psychoactive substances”, which could be used across all sectors attempting to deal with these issues, especially the NHS and enforcement agencies.
It is crucial to ensure that we get the definition of NPS right in this Bill. Speaking as a new Member, I often wonder whether it is just the way things are done here, but I am quite certain that most Members would agree it is not acceptable to have reached this stage of legislation while still not having a definition with which everyone can agree. Most alarmingly, the chair of the Advisory Council on the Misuse of Drugs has said that the definition we are being asked to agree to is unworkable. I urge the Bill Committee to consider the evidence of the ACMD and find a workable definition.